RxDoctor Payments Data

Robert Kiser, MD

Clinical Cardiac Electrophysiology · Fort Collins, CONPI 1407976111

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (52.7%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Abbott at 56.8% of the total. Reporting peaked in 2023 at $2,370 and has fallen 64.6% since, to $839 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in CO, where the typical reported total is $11,587.

$9,116in general payments, 2019–2025

Across 122 payments — averaging $74.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$5K
  • Boston Scientific$2K
  • ZOLL Respicardia, Inc.$1K
  • Medtronic$346
  • Biotronik Inc.$268
  • Biosense Webster, Inc.$100
  • plus $69 from 3 others
$26,113in research payments, 2019–2025

Across 10 payments — averaging $2611.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$26K

What the payments were for

  • Consulting fees$1,66318%
  • Travel & lodging$2,65229%
  • Food & beverage$4,80253%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,116 in reported general payments places this provider in the 45th percentile of 66 clinical cardiac electrophysiology providers in Colorado.

See all clinical cardiac electrophysiology providers in Colorado

Medicare billing

Part B allowed, 2024
$322,849
Medicare patients
3,202
Services billed
5,340

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban279$373,243
XareltoRivaroxaban73$89,456
MultaqDronedarone Hcl27$42,625
Flecainide Acetate115$6,167
Amiodarone Hcl159$3,113
Dofetilide20$3,090
Metoprolol Succinate183$2,863
Diltiazem 24hr Er (Cd)Diltiazem Hcl73$1,921
Enoxaparin Sodium12$1,211
ClopidogrelClopidogrel Bisulfate79$1,184
SotalolSotalol Hcl37$937
Warfarin Sodium81$614
Metoprolol Tartrate85$512
Carvedilol21$266
Furosemide19$128

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Fort Collins

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →